Monivent Past Earnings Performance
Past criteria checks 0/6
Monivent's earnings have been declining at an average annual rate of -27.8%, while the Medical Equipment industry saw earnings growing at 5.8% annually. Revenues have been growing at an average rate of 9.3% per year.
Key information
-27.8%
Earnings growth rate
-5.7%
EPS growth rate
| Medical Equipment Industry Growth | 6.2% |
| Revenue growth rate | 9.3% |
| Return on equity | -301.9% |
| Net Margin | -396.9% |
| Next Earnings Update | 16 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Monivent makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 4 | -14 | 15 | 0 |
| 30 Sep 23 | 4 | -15 | 16 | 0 |
| 30 Jun 23 | 4 | -15 | 16 | 0 |
| 31 Mar 23 | 3 | -16 | 16 | 0 |
| 31 Dec 22 | 4 | -14 | 16 | 0 |
| 30 Sep 22 | 4 | -13 | 14 | 0 |
| 30 Jun 22 | 3 | -13 | 13 | 0 |
| 31 Mar 22 | 3 | -12 | 12 | 0 |
| 31 Dec 21 | 2 | -12 | 11 | 0 |
| 30 Sep 21 | 1 | -12 | 11 | 0 |
| 30 Jun 21 | 1 | -11 | 9 | 0 |
| 31 Mar 21 | 1 | -9 | 8 | 0 |
| 31 Dec 20 | 2 | -7 | 8 | 0 |
| 30 Sep 20 | 3 | -6 | 7 | 0 |
| 30 Jun 20 | 3 | -5 | 8 | 0 |
| 31 Mar 20 | 3 | -5 | 8 | 0 |
| 31 Dec 19 | 3 | -5 | 7 | 0 |
| 31 Dec 18 | 3 | -3 | 5 | 0 |
| 31 Dec 17 | 1 | -2 | 3 | 0 |
| 31 Dec 16 | 1 | -2 | 2 | 0 |
Quality Earnings: MONI is currently unprofitable.
Growing Profit Margin: MONI is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MONI is unprofitable, and losses have increased over the past 5 years at a rate of 27.8% per year.
Accelerating Growth: Unable to compare MONI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MONI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (30.1%).
Return on Equity
High ROE: MONI has a negative Return on Equity (-301.85%), as it is currently unprofitable.